Back
Apellis Pharmaceuticals Vs. Doximity Industry Stock Comparison
Sell
44
APLS
Apellis Pharmaceuticals
Last Price:
28.30
Seasonality Move:
20.78%
Buy
72
DOCS
Doximity
Last Price:
52.83
Seasonality Move:
-1.56%
Sell
44
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.23. The Score for APLS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Doximity (DOCS)
is a Buy
Is Doximity a Buy, Sell or Hold?
- The current Doximity [DOCS] share price is $52.86. The Score for DOCS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- DOCS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
DOCS Stock Price Chart
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 46.19 | Sell |
| Chaikin Money Flow: | -1450356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.99 - 28.75) | Buy |
| Bollinger Bands (100): | (29.38 - 39.28) | Sell |
DOCS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.48 | Buy |
| Relative Strength Index (14 RSI): | 63.18 | Buy |
| Chaikin Money Flow: | -3634472 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.13 - 50.63) | Buy |
| Bollinger Bands (100): | (28.92 - 44.22) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.91 | Sell |
| 20-day SMA: | 28.03 | Buy |
| 50-day SMA: | 30.65 | Sell |
| 200-day SMA: | 43.67 | Sell |
| 8-day EMA: | 28.77 | Sell |
| 20-day EMA: | 28.57 | Sell |
| 50-day EMA: | 30.49 | Sell |
| 200-day EMA: | 40.29 | Sell |
DOCS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.99 | Buy |
| 20-day SMA: | 45.27 | Buy |
| 50-day SMA: | 42.69 | Buy |
| 200-day SMA: | 31.81 | Buy |
| 8-day EMA: | 51.6 | Buy |
| 20-day EMA: | 47.19 | Buy |
| 50-day EMA: | 42.9 | Buy |
| 200-day EMA: | 34.42 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Doximity Earnings Growth & DOCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
Apellis Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Doximity Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||